Updates are available Correction dated 2024-10-03
Click to view Correction: https://doi.org/10.1038/s44319-024-00212-8
-
Authors
Maeda, Sumihiro
Djukic, Biljana
Taneja, Praveen
Yu, Gui‐Qiu
Lo, Iris
Davis, Allyson
Craft, Ryan
Guo, Weikun
Wang, Xin
Kim, Daniel
Ponnusamy, Ravikumar
Gill, T Michael
Masliah, Eliezer
Mucke, Lennart
-
Funding
Funding for this research was provided by:
NIH (NS041787)
NIH (P30NS065780)
NIH Extramural Research Facilities Improvement Program Project (C06 RR018928)
Gladstone Institutes' Neurobehavioral Core
- License Information
-
More Information
Article History
Received: 23 September 2015
Revised: 1 December 2015
Accepted: 13 January 2016
First Online: 1 March 2016
Change Date: 18 March 2016
Change Type: Update
Change Details: The copyright line of this article was changed on 18 March 2016 after original online publication.
Change Date: 3 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s44319-024-00212-8
Conflict of interest
: L.M. receives research support from Bristol‐Myers Squibb and serves as a scientific advisory board member for Acumen Pharmaceuticals, Alkahest, E‐scape Bio, and Neuropore Therapies.
